<p>Squarepoint Ops LLC 在第二季度購買了 Ingevity Corporation (NYSE:NGVT - 免費報告) 的新頭寸，根據其最近向證券交易委員會 (SEC) 提交的文件。該基金購買了 29,690 股公司股票，價值約 1,279,000 美元。截至其最近向證券交易委員會 (SEC) 提交的文件，Squarepoint Ops LLC 擁有 Ingevity 約 0.08% 的股份。</p>
<p>其他機構投資者和對沖基金最近也調整了對該公司的持股。Vision One Management Partners LP 在第一季度將其在 Ingevity 的股份增加了 1.6%。Vision One Management Partners LP 目前擁有 417,178 股公司股票，價值 16,516,000 美元，在此期間又購買了 6,500 股。Range Financial Group LLC 在第二季度購買了 Ingevity 的新頭寸，價值約 1,326,000 美元。德克薩斯州教師退休系統在第二季度將其在 Ingevity 的股份增加了 82.1%。德克薩斯州教師退休系統目前擁有 36,312 股公司股票，價值 1,565,000 美元，在此期間又獲得了 16,366 股。Nuveen LLC 在第一季度獲得了 Ingevity 的新股份，價值約 4,228,000 美元。最後，Simcoe Capital Management LLC 在第一季度購買了 Ingevity 的新股份，價值約 8,568,000 美元。目前，91.59% 的股票由機構投資者持有。</p>
<h2>Ingevity 股票表現</h2>
<p>NYSE NGVT 週五開盤價為 58.62 美元。該公司的 50 日移動平均價格為 53.47 美元，200 日移動平均價格為 51.38 美元。該公司的市值為 21.1 億美元，市盈率為 -32.21，貝塔係數為 1.40。該公司的債務與股本比率為 8.39，流動比率為 1.27，速動比率為 0.80。Ingevity Corporation 的一年低點為 28.49 美元，一年高點為 61.77 美元。</p>
<p>Ingevity (NYSE:NGVT - 獲取免費報告) 最近於 3 月 24 日發佈了季度財報。該公司報告季度每股收益為 0.78 美元。該業務的季度收入為 3.36 億美元。Ingevity 的淨利潤率為 -5.14%，股本回報率為 103.69%。作為一個整體，股票研究分析師預測 Ingevity Corporation 本財年的每股收益將達到 4.45。</p>
<h2>分析師評級變動</h2>
<p>NGVT 最近成為多份研究報告的主題。華爾街 Zen 在 12 月 6 日的報告中將 Ingevity 的評級從 &#34;強力買入&#34; 下調至 &#34;買入&#34;。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Ingevity 股票的 &#34;賣出 (d-)&#34; 評級。BMO Capital Markets 在 12 月 10 日的報告中將 Ingevity 股票的目標價從 64.00 美元上調至 70.00 美元，並給予該公司 &#34;跑贏大盤&#34; 的評級。Zacks Research 在 12 月 16 日的報告中將 Ingevity 股票的評級上調至 &#34;持有&#34;。最後，富國銀行在週五的研究報告中將 Ingevity 股票的目標價從 55.00 美元上調至 60.00 美元，並給予該公司 &#34;等權重&#34; 的評級。一位研究分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該公司目前的共識評級為 &#34;持有&#34;，平均目標價為 65.00 美元。</p>
<p><strong>查看我們關於 NGVT 的最新股票報告</strong></p>
<h2>Ingevity 公司簡介</h2>
<p>(免費報告)</p>
<p>Ingevity Corporation，交易代碼為 NGVT，是一家總部位於南卡羅來納州北查爾斯頓的特種化學品和性能材料公司。該公司運營兩個主要業務部門：性能化學品和性能材料。性能化學品部門生產和銷售主要來源於木材和其他天然原料的特種化學品，包括松香酸、塔油脂肪酸和酯，以及特種石油樹脂。這些產品服務於廣泛的行業，包括紙張、粘合劑、塗料、油田鑽探和消費品。</p>
<p>性能材料部門開發和製造用於汽車排放控制、工業空氣和水淨化以及泄漏控制等應用的活性炭產品和複合材料。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票超過 Ingevity</li>
<li>資產配置：成功投資組合的關鍵。你在關注自己的投資組合嗎？</li>
<li>這三家銀行在年末前上漲，但這種趨勢會持續嗎？</li>
<li>即將到來的 IPO 股票鎖定期，解讀</li>
<li>三隻飆升的股票剛剛獲得標準普爾 500 指數的最終認可</li>
<li>Roth IRA 計算器：計算你的潛在回報</li>
<li>這隻 ETF 在美聯儲降息後獲得了重大助力</li>
</ul>
<p><strong>想看看其他對沖基金持有的 NGVT 嗎？</strong> 訪問 HoldingsChannel.com 獲取 Ingevity Corporation (NYSE:NGVT - 免費報告) 的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5HVlQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5HVlQ"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Ingevity 嗎？</h2>
<p>在你考慮 Ingevity 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Ingevity 並不在名單上。</p>
<p>雖然 Ingevity 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

NGVT

<p>Squarepoint Ops LLC 在第二季度收購了 29,690 股 Ingevity Corporation，價值 1,279,000 美元。這筆收購代表了 Ingevity 約 0.08% 的股份。其他機構投資者也調整了他們的持股，機構投資者持有 Ingevity 股票的比例為 91.59%。Ingevity 的股票開盤價為 58.62 美元，市值為 21.1 億美元。分析師對該股票的評級不一，普遍評級為 “持有”，平均目標價格為 65.00 美元</p>

<p>Squarepoint Ops LLC bought a new position in Ingevity Corporation (NYSE:NGVT - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 29,690 shares of the company's stock, valued at approximately $1,279,000. Squarepoint Ops LLC owned approximately 0.08% of Ingevity as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>Squarepoint Ops LLC 在第二季度購買了 Ingevity Corporation (NYSE:NGVT - 免費報告) 的新頭寸，根據其最近向證券交易委員會 (SEC) 提交的文件。該基金購買了 29,690 股公司股票，價值約 1,279,000 美元。截至其最近向證券交易委員會 (SEC) 提交的文件，Squarepoint Ops LLC 擁有 Ingevity 約 0.08% 的股份。</p>
</div><p>Other institutional investors and hedge funds have also recently modified their holdings of the company. Vision One Management Partners LP grew its stake in shares of Ingevity by 1.6% in the 1st quarter. Vision One Management Partners LP now owns 417,178 shares of the company's stock valued at $16,516,000 after buying an additional 6,500 shares during the period. Range Financial Group LLC bought a new position in Ingevity in the second quarter worth approximately $1,326,000. Teacher Retirement System of Texas grew its stake in Ingevity by 82.1% in the second quarter. Teacher Retirement System of Texas now owns 36,312 shares of the company's stock valued at $1,565,000 after acquiring an additional 16,366 shares during the period. Nuveen LLC acquired a new stake in Ingevity in the first quarter valued at approximately $4,228,000. Finally, Simcoe Capital Management LLC bought a new stake in shares of Ingevity during the first quarter valued at approximately $8,568,000. 91.59% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他機構投資者和對沖基金最近也調整了對該公司的持股。Vision One Management Partners LP 在第一季度將其在 Ingevity 的股份增加了 1.6%。Vision One Management Partners LP 目前擁有 417,178 股公司股票，價值 16,516,000 美元，在此期間又購買了 6,500 股。Range Financial Group LLC 在第二季度購買了 Ingevity 的新頭寸，價值約 1,326,000 美元。德克薩斯州教師退休系統在第二季度將其在 Ingevity 的股份增加了 82.1%。德克薩斯州教師退休系統目前擁有 36,312 股公司股票，價值 1,565,000 美元，在此期間又獲得了 16,366 股。Nuveen LLC 在第一季度獲得了 Ingevity 的新股份，價值約 4,228,000 美元。最後，Simcoe Capital Management LLC 在第一季度購買了 Ingevity 的新股份，價值約 8,568,000 美元。目前，91.59% 的股票由機構投資者持有。</p>
</div><h2>Ingevity Stock Performance</h2>
<div class="lb-trans"><h2>Ingevity 股票表現</h2>
</div><p>NYSE NGVT opened at $58.62 on Friday. The company has a fifty day moving average price of $53.47 and a 200-day moving average price of $51.38. The firm has a market cap of $2.11 billion, a price-to-earnings ratio of -32.21 and a beta of 1.40. The company has a debt-to-equity ratio of 8.39, a current ratio of 1.27 and a quick ratio of 0.80. Ingevity Corporation has a 1 year low of $28.49 and a 1 year high of $61.77.</p>
<div class="lb-trans"><p>NYSE NGVT 週五開盤價為 58.62 美元。該公司的 50 日移動平均價格為 53.47 美元，200 日移動平均價格為 51.38 美元。該公司的市值為 21.1 億美元，市盈率為 -32.21，貝塔係數為 1.40。該公司的債務與股本比率為 8.39，流動比率為 1.27，速動比率為 0.80。Ingevity Corporation 的一年低點為 28.49 美元，一年高點為 61.77 美元。</p>
</div><p>Ingevity (NYSE:NGVT - Get Free Report) last released its quarterly earnings results on Friday, March 24th. The company reported $0.78 earnings per share for the quarter. The business had revenue of $336.00 million for the quarter. Ingevity had a negative net margin of 5.14% and a positive return on equity of 103.69%. As a group, equities research analysts predict that Ingevity Corporation will post 4.45 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Ingevity (NYSE:NGVT - 獲取免費報告) 最近於 3 月 24 日發佈了季度財報。該公司報告季度每股收益為 0.78 美元。該業務的季度收入為 3.36 億美元。Ingevity 的淨利潤率為 -5.14%，股本回報率為 103.69%。作為一個整體，股票研究分析師預測 Ingevity Corporation 本財年的每股收益將達到 4.45。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>NGVT has been the topic of a number of recent research reports. Wall Street Zen cut Ingevity from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a report on Saturday, December 6th. Weiss Ratings reaffirmed a &#34;sell (d-)&#34; rating on shares of Ingevity in a research note on Wednesday, October 8th. BMO Capital Markets lifted their price objective on shares of Ingevity from $64.00 to $70.00 and gave the company an &#34;outperform&#34; rating in a report on Wednesday, December 10th. Zacks Research upgraded shares of Ingevity to a &#34;hold&#34; rating in a report on Tuesday, December 16th. Finally, Wells Fargo &amp; Company raised their price target on shares of Ingevity from $55.00 to $60.00 and gave the company an &#34;equal weight&#34; rating in a research report on Friday. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of &#34;Hold&#34; and an average target price of $65.00.</p>
<div class="lb-trans"><p>NGVT 最近成為多份研究報告的主題。華爾街 Zen 在 12 月 6 日的報告中將 Ingevity 的評級從 &#34;強力買入&#34; 下調至 &#34;買入&#34;。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Ingevity 股票的 &#34;賣出 (d-)&#34; 評級。BMO Capital Markets 在 12 月 10 日的報告中將 Ingevity 股票的目標價從 64.00 美元上調至 70.00 美元，並給予該公司 &#34;跑贏大盤&#34; 的評級。Zacks Research 在 12 月 16 日的報告中將 Ingevity 股票的評級上調至 &#34;持有&#34;。最後，富國銀行在週五的研究報告中將 Ingevity 股票的目標價從 55.00 美元上調至 60.00 美元，並給予該公司 &#34;等權重&#34; 的評級。一位研究分析師對該股票給予了買入評級，兩位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該公司目前的共識評級為 &#34;持有&#34;，平均目標價為 65.00 美元。</p>
</div><p><strong>Read Our Latest Stock Report on NGVT</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 NGVT 的最新股票報告</strong></p>
</div><h2>Ingevity Company Profile</h2>
<div class="lb-trans"><h2>Ingevity 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.</p>
<div class="lb-trans"><p>Ingevity Corporation，交易代碼為 NGVT，是一家總部位於南卡羅來納州北查爾斯頓的特種化學品和性能材料公司。該公司運營兩個主要業務部門：性能化學品和性能材料。性能化學品部門生產和銷售主要來源於木材和其他天然原料的特種化學品，包括松香酸、塔油脂肪酸和酯，以及特種石油樹脂。這些產品服務於廣泛的行業，包括紙張、粘合劑、塗料、油田鑽探和消費品。</p>
</div><p>The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.</p>
<div class="lb-trans"><p>性能材料部門開發和製造用於汽車排放控制、工業空氣和水淨化以及泄漏控制等應用的活性炭產品和複合材料。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Ingevity</li>
<li>Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?</li>
<li>These 3 Banks Are Rallying Into Year-End, But Will It Continue?</li>
<li>Upcoming IPO Stock Lockup Period, Explained</li>
<li>3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&amp;P 500</li>
<li>Roth IRA Calculator: Calculate Your Potential Returns</li>
<li>This ETF Caught a Major Tailwind After the Fed’s Rate Cut</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 Ingevity</li>
<li>資產配置：成功投資組合的關鍵。你在關注自己的投資組合嗎？</li>
<li>這三家銀行在年末前上漲，但這種趨勢會持續嗎？</li>
<li>即將到來的 IPO 股票鎖定期，解讀</li>
<li>三隻飆升的股票剛剛獲得標準普爾 500 指數的最終認可</li>
<li>Roth IRA 計算器：計算你的潛在回報</li>
<li>這隻 ETF 在美聯儲降息後獲得了重大助力</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding NGVT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVT - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有的 NGVT 嗎？</strong> 訪問 HoldingsChannel.com 獲取 Ingevity Corporation (NYSE:NGVT - 免費報告) 的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5HVlQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=NGVT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Ingevity Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Ingevity 嗎？</h2>
</div><p>Before you consider Ingevity, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Ingevity 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingevity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Ingevity 並不在名單上。</p>
</div><p>While Ingevity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Ingevity 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Squarepoint Ops LLC 已收購了 Ingevity Corporation $NGVT 的 29,690 股股份